Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives by Byeong-Hyeon Kim, Sujin Kim, Yunkwon Nam, Yong Ho Park, Seong Min Shin, Minho Moon

Subjects: Get full text

Subcortical signal alteration of corticospinal tracts. A radiologic manifestation of ARIA: A case report by Houman Sotoudeh, MD, Mohammadreza Alizadeh, MD, Ramin Shahidi, MD, Parnian Shobeiri, MD, MPH, Natelson love, MD, Aparna Singhal, MD

Subjects: Get full text

Symptomatic amyloid‐related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab by Lawren VandeVrede, Daniel M Gibbs, Mary Koestler, Renaud La Joie, Peter A. Ljubenkov, Karine Provost, David Soleimani‐Meigooni, Amelia Strom, Elena Tsoy, Gil D. Rabinovici, Adam L. Boxer

Subjects: Get full text

In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model by Roxana Aldea, Hans Peter Grimm, Ronald Gieschke, Carsten Hofmann, Dominik Lott, Szofia Bullain, Paul Delmar, Gregory Klein, Marco Lyons, Fabrizio Piazza, Roxana O. Carare, Norman A. Mazer

Subjects: Get full text

Imaging spectrum of amyloid-related imaging abnormalities associated with aducanumab immunotherapy by Houman Sotoudeh, Mohammadreza Alizadeh, Ramin Shahidi, Parnian Shobeiri, Zahra Saadatpour, C. Austin Wheeler, Marissa Natelson Love, Manoj Tanwar

Subjects: Get full text

Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease by Charles G. Withington, R. Scott Turner

Subjects: Get full text

Use of Artificial Intelligence in Imaging Dementia by Manal Aljuhani, Azhaar Ashraf, Paul Edison

Subjects: Get full text

Lecanemab for mild Alzheimer disease – is there a way forward? by Rajesh R Tampi

Subjects: Get full text

Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2a studyResearch i... by Hui Jing Yu, Samuel P. Dickson, Pei-Ning Wang, Ming-Jang Chiu, Chin-Chang Huang, Chiung-Chih Chang, Hope Liu, Suzanne B. Hendrix, Jean-Cosme Dodart, Ajay Verma, Chang Yi Wang, Jeffrey Cummings

Subjects: Get full text

APOE-ε4 allele[s]-associated adverse events reported from placebo arm in clinical trials for Alzheimer's disease: implications for anti-amyloid beta therapy by Kenichiro Sato, Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, Kazushi Suzuki, Atsushi Iwata, Takeshi Iwatsubo, Takeshi Iwatsubo

Subjects: Get full text

Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023 by Alexander C. Martins, Mariana Y. Oshiro, Fernando Albericio, Beatriz G. de la Torre

Subjects: Get full text

Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol by Jimin Kim, Eunhee Kim, Mina Park, Yun Jung Bae, Chong Hyun Suh, Sung-Hye You, Younghee Yim, Ho-Joon Lee, Jin Wook Choi, Se Won Oh, Won-Jin Moon

Subjects: Get full text

Donanemab in Japanese Patients with Early Alzheimer’s Disease: Subpopulation Analysis of the TRAILBLAZER-ALZ 2 Randomized Trial by Shoichiro Sato, Naohisa Hatakeyama, Shinji Fujikoshi, Sadao Katayama, Hideaki Katagiri, John R. Sims

Subjects: Get full text

Regional Variability in MRI Scans with Different Magnetic Field Strengths in Japan: Implications for Healthcare Preparedness for Alzheimer’s Disease Treatment by Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, Atsushi Iwata, Takeshi Iwatsubo

Subjects: Get full text

Aducanumab: evidence from clinical trial data and controversies by Rajesh R Tampi, Brent P Forester, Marc Agronin

Subjects: Get full text

Rapid Cognitive Decline and Recurrent Falls in a 71 Year-Old Man due to Cerebral Amyloidangiopathy-Related Inflammation (CAA-RI) by Stefan Dörr, Rabea Schickel, Lara Lucke-Paulig, Steffen Schöntag, Ralf Lobmann

Subjects: Get full text

Editorial: Cerebral amyloid angiopathy: from bench to bedside by Hamid R. Sohrabi, Hamid R. Sohrabi, Steven M. Greenberg, Luke Whiley

Subjects: Get full text